TP53 and pancreatic neoplasm: For series 1, 93 considerably enriched pathways (FDR <0.05) were identified, which include the p53 signalling pathway, Pancreatic cancer, PI3K-Akt signalling pathway, IL-17 signalling pathway, Toll-like receptor signalling pathway, MAPK signalling pathway and TNF signalling pathway.